financetom
Business
financetom
/
Business
/
PRESS DIGEST- Financial Times - March 15
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST- Financial Times - March 15
Mar 14, 2024 6:17 PM

March 15 (Reuters) - The following are the top stories

in the Financial Times. Reuters has not verified these stories

and does not vouch for their accuracy.

Headlines

- RedBird IMI favours Telegraph sale after Sunak moved to

block deal

- Shell shakes up climate targets as it plans to keep gas

business growing

- UK statisticians threaten strike action over

back-to-office mandate

- Munich prosecutor opens money laundering probe into Signa

Overview

- RedBird IMI is leaning towards a full sale of Telegraph

Media Group following the British government's decision to block

its Abu Dhabi-backed takeover of the newspaper.

- Shell has weakened some of its climate targets to

accommodate plans to keep growing its giant gas business, even

as it reaffirmed its long-term commitment to cut emissions to

net zero by 2050.

- Staff at the Britain's statistics agency are threatening

strike action after being ordered back to the office as part of

a wider ministerial clampdown on homeworking across the civil

service.

- Munich's state prosecutor is looking into allegations of

money laundering at the Signa Group, René Benko's collapsed

luxury property empire.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences Says Twice-Yearly HIV Treatment Lenacapavir Reduces Infections by 96%
Gilead Sciences Says Twice-Yearly HIV Treatment Lenacapavir Reduces Infections by 96%
Sep 12, 2024
09:28 AM EDT, 09/12/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Thursday that a second phase 3 clinical study of lenacapavir, the company's twice-yearly injectable HIV-1 capsid inhibitor, lowered HIV infection rate by 96% in comparison to background HIV incidence. There were only two incident cases out of 2,180 participants who acquired the HIV infection in the lenacapavir...
Climb Global Solutions Unit Climb Channel Says Keyfactor is New Partner in North America
Climb Global Solutions Unit Climb Channel Says Keyfactor is New Partner in North America
Sep 12, 2024
09:24 AM EDT, 09/12/2024 (MT Newswires) -- Climb Global Solutions ( CLMB ) unit Climb Channel Solutions said Thursday that it is launching a partnership with Keyfactor to boost the availability of public key infrastructure and machine identity management services to companies in North America. Partners inside Climb Channel Solutions' community will get access to Keyfactor's service for issuing and...
Atlas Partners to invest in Carlyle's Sedgwick
Atlas Partners to invest in Carlyle's Sedgwick
Sep 12, 2024
Sept 12 (Reuters) - Carlyle-owned Sedgwick on Thursday announced a strategic investment from Atlas Partners that will imply a total enterprise value of $13.2 billion. ...
Commerzbank, UniCredit shares extend gains as Orcel lays out plans
Commerzbank, UniCredit shares extend gains as Orcel lays out plans
Sep 12, 2024
MILAN (Reuters) - Commerzbank and UniCredit shares extended gains on Thursday after the Italian bank's CEO Andrea Orcel laid out plans to buy more of its German rival or even take it over, fuelling speculation about further dealmaking in the region. By 0845 GMT shares in Commerzbank were up 2.6%, rising further after Orcel told Bloomberg TV that on the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved